Apple (AAPL - Free Report) is firing on all cylinders to strengthen its position in the wearable world on the back of robust technologies and innovative products.
Recently, the company announced a new update for its Apple Watch Series 4, with primary focus on user fitness. The update enables users to access ECG app on their watch. This move will likely aid users in detecting atrial fibrillation (a-fib) or irregular heartbeat.
A recent study conducted by Stanford Medical School, which was funded by the iPhone maker, suggested that Apple watch was able to detect irregular heart pulses in a significant number of users.
Notably, more than 400,000 people participated in this study. Among the ones who participated, only 0.5% received a notification for irregular heartbeat. On receiving the alert, participants had to consult a study doctor and wear an EKG patch for a week to validate the accuracy of the alert.
Irregular heart pattern more than once a week is indicative of a-fib. It’s noteworthy that one third of the participants who carried the EKG patch were found to have the problem.
Apple Inc. Price and Consensus
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Apple (AAPL - Free Report) is firing on all cylinders to strengthen its position in the wearable world on the back of robust technologies and innovative products.
Recently, the company announced a new update for its Apple Watch Series 4, with primary focus on user fitness. The update enables users to access ECG app on their watch. This move will likely aid users in detecting atrial fibrillation (a-fib) or irregular heartbeat.
A recent study conducted by Stanford Medical School, which was funded by the iPhone maker, suggested that Apple watch was able to detect irregular heart pulses in a significant number of users.
Notably, more than 400,000 people participated in this study. Among the ones who participated, only 0.5% received a notification for irregular heartbeat. On receiving the alert, participants had to consult a study doctor and wear an EKG patch for a week to validate the accuracy of the alert.
Irregular heart pattern more than once a week is indicative of a-fib. It’s noteworthy that one third of the participants who carried the EKG patch were found to have the problem.
Apple Inc. Price and Consensus
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on AAPL - FREE
Get the latest research report on GRMN - FREE